COMPOSITIONS FOR A DIETARY SUPPLEMENT TO IMPROVE SLEEP
20210299097 · 2021-09-30
Inventors
Cpc classification
A61K31/575
HUMAN NECESSITIES
A61K31/205
HUMAN NECESSITIES
A61K31/198
HUMAN NECESSITIES
A61K31/352
HUMAN NECESSITIES
A61K31/575
HUMAN NECESSITIES
A61K9/0053
HUMAN NECESSITIES
A61K36/81
HUMAN NECESSITIES
A61K2300/00
HUMAN NECESSITIES
A61K2300/00
HUMAN NECESSITIES
A61K31/405
HUMAN NECESSITIES
A61K33/06
HUMAN NECESSITIES
A61K31/405
HUMAN NECESSITIES
A61K9/48
HUMAN NECESSITIES
A61K36/53
HUMAN NECESSITIES
A61K36/45
HUMAN NECESSITIES
A61K31/7048
HUMAN NECESSITIES
A61K31/7048
HUMAN NECESSITIES
A61K45/06
HUMAN NECESSITIES
A61K33/06
HUMAN NECESSITIES
A61K36/53
HUMAN NECESSITIES
A61K31/122
HUMAN NECESSITIES
A61K36/81
HUMAN NECESSITIES
A61K31/198
HUMAN NECESSITIES
A61K31/205
HUMAN NECESSITIES
A61K31/352
HUMAN NECESSITIES
A61K31/122
HUMAN NECESSITIES
A61K36/45
HUMAN NECESSITIES
A61K31/7072
HUMAN NECESSITIES
International classification
A61K31/405
HUMAN NECESSITIES
A61K31/122
HUMAN NECESSITIES
A61K31/198
HUMAN NECESSITIES
A61K31/7048
HUMAN NECESSITIES
A61K31/7072
HUMAN NECESSITIES
A61K45/06
HUMAN NECESSITIES
Abstract
A composition for improving sleep. In one embodiment, the composition comprises L-Tryptophan, L-Theanine, Reishi mushroom extract, Uridine, a polyphenol, and paeoniflorin. In certain embodiments, the composition further comprises citrus bioflavonoid extract, γ-Oryzanol, holy basil extract, saffron extract, Schisandra chinensis extract, sesamin extract, blueberry extract, quercetin, Polygala tenufolia root extract, gotu kola extract, ashwagandha extract, betaine, magnesium, or combinations thereof. In other embodiments, the composition further comprises astaxanthin, lycopene, hawthorne extract, or combinations thereof. In certain embodiments, the composition is incorporated into pills. A method for promoting the brain pathways involved in sleep, relaxation, and calmness comprising: ingesting a composition comprising L-Tryptophan, L-Theanine, Reishi mushroom extract, Uridine, a polyphenol, and paeoniflorin. In one method, the composition is ingested at least one and a half hours before bedtime.
Claims
1. A composition comprising L-Tryptophan, L-Theanine, Reishi mushroom extract, Uridine, a polyphenol, and paeoniflorin.
2. The composition of claim 1 further comprising citrus bioflavonoid extract, γ-Oryzanol, holy basil extract, saffron extract, Schisandra chinensis extract, sesamin extract, blueberry extract, quercetin, Polygala tenuifolia root extract, gotu kola extract, ashwagandha extract, betaine, magnesium, or combinations thereof.
3. The composition of claim 2 further comprising astaxanthin, lycopene, hawthorn extract, or combinations thereof.
4. The composition of claim 1, wherein the composition is integrated into a capsule, tablet, chewable tablet, or pill.
5. The composition of claim 1, wherein the composition is integrated into a liquid or powder.
6. A method for promoting the brain pathways involved in sleep, relaxation, and calmness comprising: ingesting a composition comprising L-Tryptophan, L-Theanine, Reishi mushroom extract, Uridine, a polyphenol, and paeoniflorin.
7. The method of claim 6, wherein the step of ingesting occurs at least one and a half hours before bedtime.
8. The method of claim 6, wherein the composition further comprises citrus bioflavonoid extract, γ-Oryzanol, holy basil extract, saffron extract, Schisandra chinensis extract, sesamin extract, blueberry extract, quercetin, Polygala tenuifolia root extract, gotu kola extract, ashwagandha extract, betaine, magnesium, or combinations thereof.
9. The method of claim 7, wherein the composition further comprises astaxanthin, lycopene, hawthorn extract, or combinations thereof.
10. The method of claim 6, wherein the composition is integrated into a capsule, tablet, chewable tablet, or pill.
11. The method of claim 6, wherein the composition is integrated into a liquid or powder.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0013] For a more complete understanding of the present invention, the objects and advantages thereof, reference is now made to the ensuing descriptions taken in connection with the accompanying drawings briefly described as follows:
[0014]
[0015]
[0016]
DETAILED DESCRIPTION OF THE EMBODIMENTS
[0017] Preferred embodiments of the present invention and their advantages may be understood by referring to
[0018] Reference throughout this specification to “one embodiment,” “an embodiment,” or similar language means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, appearances of the phrases “in one embodiment,” “in an embodiment,” and similar language throughout this specification may, but do not necessarily, all refer to the same embodiment.
[0019] Moreover, the described features, structures, or characteristics of the invention may be combined in any suitable manner in one or more embodiments. It will be apparent to those skilled in the art that various modifications and variations can be made to the present invention without departing from the spirit and scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents. Reference will now be made in detail to the preferred embodiments of the invention.
[0020] In an exemplary embodiment of the present invention and with reference to
[0021] The present composition may be administered orally. In such an embodiment, the sleep aid may be integrated into a liquid, capsule, tablet, chewable tablet, or pill. In an exemplary embodiment, the composition is integrated into capsules and taken orally with dinner and/or in the time period leading up to bedtime (approximately 1.5-3 hours prior to desired bedtime).
[0022] The composition works unexpectedly well in that by taking the composition several hours before bedtime, the composition has a more robust effect in inducing sleep naturally. The method of taking the composition several hours before bedtime, as opposed to just prior to sleep as described in previous sleep compositions, results in a more productive day after sleep by not causing sedative-like effects. The composition further works unexpectedly well in that by combining smaller doses of compounds that assist with the brain's sleep pathways with anti-oxidant and anti-inflammatory chemical compounds, the composition assists with sleep but additionally makes the user have a more productive day the following day. The constituents form a synergistic compound where the combined effect is greater than the sum of their separate effects.
[0023] In an exemplary embodiment of the present invention and with reference to
[0024] In an exemplary embodiment of the present invention and with reference to
[0025] In addition to the exemplary ingredients disclosed, other ingredients may be used to assist administration. In an example where the sleep aid is integrated into a capsule or tablet, the composition may also include binding agents or other inactive ingredients.
[0026] The present composition may be administered orally. In such an embodiment, the sleep aid may be integrated into a liquid, capsule, tablet, chewable tablet, or pill. In an exemplary embodiment, the composition is integrated into capsules and taken orally with dinner and/or in the time period leading up to bedtime (approximately 1.5-3 hours prior to desired bedtime). In such an embodiment, a dietary supplement to improve sleep may be prepared by first combining L-Tryptophan, L-Theanine, Reishi mushroom extract, uridine, polyphenols, and paeoniflorin (as exemplary ingredients) and mixing until a homogeneous mixture is produced. The composition may then be integrated into capsules to be taken orally.
[0027] The present disclosure may also be administered to a patient in other ways without departing from the embodiments contemplated herein including: pressing into a tablet form, including in a food or beverage, and other related methods of oral ingestion.
[0028] To make the composition, one takes the ingredients as described in the exemplary embodiments and mixes them in powder form until a homogeneous mixture is achieved. The composition is then packaged into capsules to be taken orally.
[0029] The invention has been described herein using specific embodiments for the purposes of illustration only. It will be readily apparent to one of ordinary skill in the art, however, that the principles of the invention can be embodied in other ways. Therefore, the invention should not be regarded as being limited in scope to the specific embodiments disclosed herein, but instead as being fully commensurate in scope with the following claims.